- Home
- TNC vs BHVN Comparison
TNC vs BHVN Comparison
Compare TNC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNC
- BHVN
- Stock Information
- Founded
- TNC 1870
- BHVN 2013
- Country
- TNC United States
- BHVN United States
- Employees
- TNC N/A
- BHVN N/A
- Industry
- TNC Industrial Machinery/Components
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- TNC Industrials
- BHVN Health Care
- Exchange
- TNC Nasdaq
- BHVN Nasdaq
- Market Cap
- TNC 1.4B
- BHVN 1.5B
- IPO Year
- TNC N/A
- BHVN 2017
- Fundamental
- Price
- TNC $82.69
- BHVN $15.12
- Analyst Decision
- TNC Strong Buy
- BHVN Strong Buy
- Analyst Count
- TNC 1
- BHVN 14
- Target Price
- TNC $125.00
- BHVN $58.85
- AVG Volume (30 Days)
- TNC 111.0K
- BHVN 1.9M
- Earning Date
- TNC 08-06-2025
- BHVN 08-19-2025
- Dividend Yield
- TNC 1.43%
- BHVN N/A
- EPS Growth
- TNC N/A
- BHVN N/A
- EPS
- TNC 3.58
- BHVN N/A
- Revenue
- TNC $1,265,700,000.00
- BHVN N/A
- Revenue This Year
- TNC N/A
- BHVN N/A
- Revenue Next Year
- TNC $4.25
- BHVN $1,007.82
- P/E Ratio
- TNC $23.06
- BHVN N/A
- Revenue Growth
- TNC 1.35
- BHVN N/A
- 52 Week Low
- TNC $67.32
- BHVN $12.79
- 52 Week High
- TNC $98.89
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- TNC 56.39
- BHVN 53.79
- Support Level
- TNC $80.50
- BHVN $14.30
- Resistance Level
- TNC $84.13
- BHVN $16.00
- Average True Range (ATR)
- TNC 1.67
- BHVN 0.84
- MACD
- TNC -0.09
- BHVN 0.24
- Stochastic Oscillator
- TNC 69.77
- BHVN 69.78
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.